Aclaris Therapeutics to Participate in the H.C. Wainwright 4th Annual Inflammatory Skin Disease Virtual Conference
Aclaris Therapeutics, a clinical-stage biopharmaceutical company specializing in immuno-inflammatory diseases, announced participation of its CEO and senior leadership in a fireside chat at the H.C. Wainwright 4th Annual Inflammatory Skin Disease Virtual Conference on April 14, 2026. The event will be webcast live and archived on the company's webs…